Package 62332-744-31

{"route": ["ORAL"], "spl_id": "fee5919a-554b-4767-8ab2-867de799a533", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["e37c96f1-0738-49c7-ad46-c8ae0a998cf7"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (62332-744-31)", "package_ndc": "62332-744-31", "marketing_start_date": "20231004"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (62332-744-91)", "package_ndc": "62332-744-91", "marketing_start_date": "20231004"}], "brand_name": "Chlordiazepoxide hydrochloride and clidinium bromide", "product_id": "62332-744_fee5919a-554b-4767-8ab2-867de799a533", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "62332-744", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide hydrochloride and clidinium bromide", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide hydrochloride and clidinium bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA216969", "marketing_category": "ANDA", "marketing_start_date": "20231004", "listing_expiration_date": "20261231"}